Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily

Area of Science:

• Medical Science
• Immunology
• Endocrinology

Background:

• Diabetic angiopathy, a severe complication of diabetes mellitus, leads to cardiovascular disease, retinopathy, nephropathy, and neuropathy.
• Diabetic kidney disease affects a third of diabetic patients and is a primary cause of end-stage renal failure.
• Despite available treatments, diabetic angiopathy remains a leading cause of mortality and morbidity, necessitating novel therapeutic approaches.

Purpose of the Study:

• To explore the potential role of the complement system and tumor necrosis factor (TNF) superfamily in diabetic angiopathy pathogenesis.
• To identify promising biomarkers and therapeutic targets within these systems for diabetic vascular complications.

Main Methods:

• Review of recent data supporting the involvement of complement and TNF superfamily dysregulation in diabetic vascular complications.
• Identification of the mannose-binding lectin pathway as a key component of the complement system implicated in diabetic angiopathy.
• Examination of TNF superfamily members, TRAIL and osteoprotegerin, for their potential role in diabetic angiopathy pathogenesis.

Main Results:

• Dysregulation of the complement system and TNF superfamily members is hypothesized to contribute to diabetic vascular complications.
• The mannose-binding lectin pathway is identified as a promising biomarker and is directly involved in diabetic angiopathy development.
• TRAIL and osteoprotegerin are suggested as potentially involved in the pathogenesis of diabetic angiopathy.

Conclusions:

• The complement and TNF superfamily systems represent potential therapeutic targets for diabetic angiopathy.
• Further research is needed to determine if existing drugs targeting these systems can be effectively used for late diabetic complications.